Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126550) titled 'Efficacy and Mechanism of Breast Milk-Derived Limosilactobacillus reuteri FN041 in Alleviating Atopic Dermatitis in Children' on June 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Changzhou Maternal and Child Health Care Hospital
Condition:
Eczema
Intervention:
Placebo group:One placebo was administered orally twice daily for 4 consecutive weeks.
Positive control group:One sachet of lyophilized powder for the positive control group, containing three strains including *Lactobacillus rhamnosus* ATCC 53103, *Bifidobacterium animalis* subsp. *lactis* BI-07, and *Lactiplantibacill...